VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $286 | +5.9% | 11,678 | +0.6% | 0.04% | 0.0% |
| Q1 2023 | $270 | -9.4% | 11,605 | -1.3% | 0.04% | -81.1% |
| Q4 2022 | $298 | -99.9% | 11,755 | -2.9% | 0.20% | +59.3% |
| Q3 2022 | $233,000 | -29.0% | 12,105 | -5.9% | 0.12% | -26.8% |
| Q2 2022 | $328,000 | -53.9% | 12,870 | -24.3% | 0.17% | +97.6% |
| Q4 2021 | $712,000 | -14.4% | 17,001 | -11.0% | 0.08% | -29.2% |
| Q3 2021 | $832,000 | -12.6% | 19,111 | -5.1% | 0.12% | -14.9% |
| Q2 2021 | $952,000 | -5.9% | 20,131 | +2.0% | 0.14% | -22.5% |
| Q1 2021 | $1,012,000 | – | 19,744 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |